Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902604094
Pharmaceuticals
| Market Cap | 158M 139M 130M 119M 223M 15.18B 229M 1.54B 603M 7.51B 595M 582M 25.96B | P/E 2026 * |
-0.99x | P/E 2027 * | -1.58x |
|---|---|---|---|---|---|
| Enterprise Value | 158M 139M 130M 119M 223M 15.18B 229M 1.54B 603M 7.51B 595M 582M 25.96B | EV / Sales 2026 * |
4.64x | EV / Sales 2027 * | 2.01x |
| Free-Float |
99.86% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| 1 day | +83.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.42% | -17.57% | - | - | 158M | |
| -0.25% | +4.86% | +59.85% | +168.30% | 1,089B | |
| +0.18% | +4.81% | +59.38% | +59.93% | 643B | |
| +1.12% | +5.24% | +39.41% | +78.22% | 465B | |
| -1.69% | +8.81% | +39.38% | +33.67% | 359B | |
| -0.51% | +3.51% | +36.97% | +42.46% | 303B | |
| +1.50% | +3.40% | +17.71% | +17.41% | 267B | |
| +0.79% | +5.81% | -2.55% | -38.10% | 226B | |
| -0.76% | +6.67% | +28.63% | +66.76% | 212B | |
| -0.35% | +2.60% | +17.07% | +75.64% | 167B | |
| Average | +8.35% | +5.07% | +32.87% | +56.03% | 414.57B | |
| Weighted average by Cap. | -0.01% | +5.14% | +42.90% | +81.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.18M 30.04M 28.04M 25.73M 48.17M 3.27B 49.36M 332M 130M 1.62B 128M 126M 5.6B | 78.93M 69.36M 64.74M 59.42M 111M 7.56B 114M 768M 300M 3.74B 296M 290M 12.93B |
| Net income | -170M -149M -139M -128M -239M -16.28B -245M -1.65B -646M -8.06B -638M -624M -27.85B | -152M -133M -125M -114M -214M -14.54B -219M -1.48B -578M -7.2B -570M -558M -24.88B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
